Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voraxaze for methotrexate toxicity in lymphoma
NCT04668768Phase 2Suspended
- Sponsor
- Fox Chase Cancer Center
- Start
- Apr 2021
- Primary completion
- Dec 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucarpidase in nephrotoxicity, sponsored by Fox Chase Cancer Center. Started Apr 2021; status: suspended.
02
Drugs
glucarpidase
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on NCT04668768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668768.